🇺🇸 FDA
Pipeline program

CLBS119

CLBS119-P01

Phase 1 mab terminated

Quick answer

CLBS119 for Covid-19 is a Phase 1 program (mab) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
LISATA THERAPEUTICS, INC.
Indication
Covid-19
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials